Log in to save to my catalogue

Citicoline as Adjuvant Therapy in Parkinson's Disease: A Systematic Review

Citicoline as Adjuvant Therapy in Parkinson's Disease: A Systematic Review

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2467842470

Citicoline as Adjuvant Therapy in Parkinson's Disease: A Systematic Review

About this item

Full title

Citicoline as Adjuvant Therapy in Parkinson's Disease: A Systematic Review

Publisher

United States: Elsevier Inc

Journal title

Clinical therapeutics, 2021-01, Vol.43 (1), p.e19-e31

Language

English

Formats

Publication information

Publisher

United States: Elsevier Inc

More information

Scope and Contents

Contents

AbstractPurposeParkinson disease (PD) medications are not readily available in all countries. Citicoline increases dopamine synthesis and inhibits dopamine uptake. This systematic review aims to synthesize current existing evidence on the efficacy of citicoline adjunctive therapy in improving PD symptoms. MethodsAn extensive literature search of Sc...

Alternative Titles

Full title

Citicoline as Adjuvant Therapy in Parkinson's Disease: A Systematic Review

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2467842470

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2467842470

Other Identifiers

ISSN

0149-2918

E-ISSN

1879-114X

DOI

10.1016/j.clinthera.2020.11.009

How to access this item